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PPediatric Cardiovascular Disease
Childhood Levels of Serum Apolipoproteins B
and A-I Predict Carotid Intima-Media Thickness
and Brachial Endothelial Function in Adulthood
The Cardiovascular Risk in Young Finns Study
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Tiina Solakivi, PHD, Hans Helenius, MSC,† Antti Jula, MD, PHD,** Jukka Marniemi, PHD,**
Leena Taittonen, MD, PHD,††‡‡ Tomi Laitinen, MD, PHD,§§ Tapio Nikkari, MD, PHD,
Olli T. Raitakari, MD, PHD‡§
Turku, Tampere, Oulu, and Kuopio, Finland
Objectives The aim of this study was to determine whether apolipoproteins (apo) B and A-I measured in childhood and ado-
lescence predict atherosclerosis in adulthood.
Background Exposure to dyslipidemia in childhood predicts the development of atherosclerosis. Apolipoproteins B and A-I
might be good markers of atherogenic dyslipidemia, but there is a paucity of information concerning their impor-
tance in childhood.
Methods Apolipoproteins B and A-I, low-density lipoprotein (LDL)-cholesterol, high-density lipoprotein (HDL)-cholesterol,
triglycerides, blood pressure, obesity, insulin, C-reactive protein, and smoking were assessed in 1980 and 2001
among 879 subjects in the Cardiovascular Risk in Young Finns Study (ages 3 to 18 years at baseline). Carotid
artery intima-media thickness (IMT) and brachial artery flow-mediated dilation (FMD) were measured in 2001 at
the age of 24 to 39 years.
Results In subjects ages 12 to 18 years at baseline, apoB and apoB/apoA-I ratio were directly (p 0.001) related and apoA-I
was inversely (p  0.01) related with adulthood IMT. In subjects ages 3 to 18 years at baseline, apoB (p 0.02) and
the apoB/apoA-I ratio (p  0.001) were inversely related and apoA-I (p 0.003) was directly related to adulthood
FMD. These relations were not altered when the effects of nonlipid risk factors and adulthood apolipoproteins were
taken into account. The apoB/apoA-I ratio measured in adolescence was superior to LDL/HDL ratio (c-values, 0.623
vs. 0.569, p  0.03) in predicting increased IMT in adulthood (IMT90th percentile and/or carotid plaque).
Conclusions Apolipoproteins B and A-I measured in children and adolescents reflect a lipoprotein profile predisposing to the
development of subclinical atherosclerosis in adulthood. These markers might have value in pediatric lipid risk
assessment. (J Am Coll Cardiol 2008;52:293–9) © 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.03.054D
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ccepted March 18, 2008.yslipidemia is a major risk factor for atherosclerotic
iseases (1), and serum lipid values are cornerstones in
linical risk stratification. Serum concentrations of low-
ensity lipoprotein (LDL) and high-density lipoprotein
HDL) cholesterol are mainly used for this purpose. How-
ver, the amounts of LDL and HDL particles’ major
polipoproteins (apo) B and A-I could be better markers of
yslipidemia risk than their cholesterol concentration (2–8).
See page 300
Atherosclerosis begins in childhood (9). Pre-clinical vas-
ular changes can be assessed noninvasively and reliably by
ltrasound in young subjects. Increased carotid intima-
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Apolipoproteins and Early Atherosclerosis July 22, 2008:293–9media thickness (IMT) is a
marker of structural atheroscle-
rosis. It correlates with cardio-
vascular risk factors (10) and the
severity of coronary atherosclero-
sis (11) and predicts cardiovascu-
lar events (12). Vascular endo-
thelial function can be measured
by evaluating brachial artery
flow-mediated dilation (FMD)
(13). Impaired FMD predicts
cardiovascular events (14), and
preserved FMD response associ-
ates with favorable cardiovascular
outcome (15).
Exposure to atherogenic lipid
profile in early life might induce
changes in arteries that contrib-
ute to the development of ath-
erosclerosis. We (10) and others
(16,17) have shown that elevated
DL-cholesterol levels in childhood predict increased ca-
otid IMT in adulthood. In cross-sectional settings, HDL-
holesterol levels in childhood and early adulthood have
een related to decreased IMT and increased FMD
16–20).
In the present study, we aimed to examine the roles of
igh apoB/LDL cholesterol and low apoA-I/HDL choles-
erol in predicting the development of subclinical athero-
clerosis. We also tested the hypothesis that serum apoB
nd apoA-I and their ratio are better indicators of athero-
enic/antiatherogenic lipoprotein particles than the conven-
ional measures of LDL cholesterol and HDL cholesterol.
o address this, we studied whether childhood/adolescent
evels of apoB and apoA-I are predictive of carotid IMT and
rachial FMD measured 21 years later in early adulthood
mong 879 men and women. The study subjects were
articipants of the prospective Cardiovascular Risk in
oung Finns Study (10).
ethods
ubjects. The Cardiovascular Risk in Young Finns Study
s a multicenter follow-up study of atherosclerosis precursors
f Finnish children and adolescents. The first cross-
ectional survey was conducted in 1980, when 3,596 partic-
pants, ages 3, 6, 9, 12, 15, and 18 years, were randomly
hosen from the 5 study areas on the basis of the national
opulation register. In the 21-year follow-up in 2001, we
arried out vascular ultrasound studies in 2,265 of these
ndividuals, ages 24 to 39 years. Apolipoproteins B and A-I
ere measured in a subcohort of 1,341 subjects in 1980.
ue to limited analytical capacity, apolipoproteins were
easured only for this subsample of the total cohort (21).
ltogether, 879 of these 1,341 subjects with apolipoprotein
Abbreviations
and Acronyms
apo  apolipoprotein
BMI  body mass index
CHD  coronary heart
disease
CRP  C-reactive protein
CV  coefficient of
variation
FMD  flow-mediated
dilation
HDL  high-density
lipoprotein
IMT  intima-media
thickness
LDL  low-density
lipoprotein
ROC  receiver-operating
characteristicata gathered in 1980 participated in the 21-year follow-up tn 2001, comprising the present study cohort. The study has
een approved by the ethics committees of each center, and
ll subjects and/or their parents have given their written
nformed consents. The authors have had full access to the
ata and take full responsibility for their integrity.
polipoprotein and lipid measurements. Venous blood
amples were drawn after an overnight fast. In 1980, apoB
nd apoA-I were determined with a radial immunodiffusion
ethod (21). The interassay coefficient of variation (CV)
as 5.1% for apoB and 4.0% for apoA-I. In 2001, apoB and
poA-I were analyzed immunoturbidometrically (Orion
iagnostica, Espoo, Finland); interassay CVs were 2.8% for
poB and 3.2% for apoA-I. The details of other lipid deter-
ination methods have been previously published (22).
on-lipid risk factors. Height and weight were measured,
nd body mass index (BMI) was calculated. Blood pressure
as measured from the brachial artery with a standard
ercury sphygmomanometer in 1980. From 3-year-old
ubjects blood pressure was measured with an ultrasound
evice. In 2001, a random zero sphygmomanometer was
sed. The mean of 3 measurements was used in the analysis.
erum samples for youth C-reactive protein (CRP) mea-
urements were taken in 1980 and stored in 20°C. These
amples were analyzed in 2005 (23). During the storage,
he samples were not thawed or refrozen. In 1980, serum
nsulin was measured with a modification of the immu-
oassay method of Herbert et al. (24). Smoking habits
ere determined with a questionnaire in subjects ages
12 years. Regular cigarette smoking on a weekly basis
r more often was defined as a risk factor for smoking.
ltrasound imaging. Ultrasound studies of the carotid and
rachial arteries were performed with Sequoia512 ultra-
ound mainframes (Acuson, Mountain View, California)
ith 13.0 MHz linear array transducer (10,20). To assess
ntraindividual reproducibility of ultrasound measurements,
7 subjects were re-examined 3 months after the initial visit.
arotid IMT. Carotid IMT was measured on the poste-
ior (far) wall of the left carotid artery. At least 4 measure-
ents were taken approximately 10 mm proximal to the
ifurcation to derive mean carotid IMT. The between-visit
V was 6.4% (10). The far and near walls of the left
ommon carotid artery and carotid bulb area were scanned
or the presence of atherosclerotic plaque, defined as a
istinct area of the vessel wall protruding into the lumen
50% of the adjacent intima-media layer (25).
rachial FMD. To assess brachial FMD, the left brachial
rtery diameter was measured at rest and during reactive
yperemia. Increased flow was induced by inflation of a
neumatic tourniquet placed around the forearm to a
ressure of 250 mm Hg for 4.5 min, followed by a release
20). Arterial diameter was measured at end-diastole at a
xed distance from an anatomic marker at rest and 40, 60,
nd 80 s after cuff release. The vessel diameter in scans after
eactive hyperemia was expressed as the percentage relative
o resting scan. The average of 3 measurements at each time
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July 22, 2008:293–9 Apolipoproteins and Early Atherosclerosisoint was used to derive the maximum FMD (the greatest
alue between 40 and 80 s). The between-visit CV for
rachial diameter was 3.2% and for FMD 26.0% (20).
tatistical methods. To examine possible selection bias,
he clinical characteristics between subjects of the present
1-year follow-up who had had their serum apolipoproteins
easured in 1980 (“study subjects”) and those whose apo-
ipoprotein values were not available (“excluded due to
issing data”) were compared with the t test for continuous
ariables and chi-square test for categorical variables.
To study the relations between apolipoproteins and
arkers of subclinical atherosclerosis, we first examined the
ivariate associations with age- and gender-specific Z score
alues (standardized values) for apolipoproteins. Then, we
tudied the independent effects of apolipoproteins on sub-
linical atherosclerosis. Therefore, multivariable models in-
luding age- and gender-specific Z score values for blood
ressure, triglycerides, BMI, CRP, insulin, and brachial
iameter (in FMD models) and absence/presence of smok-
ng were constructed. Finally, we investigated whether the
ffects of childhood apolipoproteins are independent of the
dulthood values, by including Z score values of adulthood
polipoproteins in multivariable models.
Possible risk factor  gender and risk factor  age
nteractions were tested with linear regression models.
ecause there were no significant gender interactions in the
ssociations of apolipoproteins with IMT or FMD, the
nalyses were performed with genders combined. There
ere significant apoB  age (p  0.002), apoA-I  age
p  0.007), and apoB/apoA-I ratio  age (p  0.001)
nteractions when studying their associations with IMT.
herefore, as in our prior report concerning associations
etween conventional childhood risk factors and adulthood
MT (10), the analyses concerning IMT were performed
eparately for subjects ages 3 to 9 and 12 to 18 years at
aseline. This age stratification paralleled pubertal staging,
ecause approximately 85% of 12- to 18-year-old subjects at
aseline were classified having puberty on-going or com-
leted (Tanner staging). The results of the regression
nalyses were essentially similar with either pubertal stage or
ge group stratification. The relations between apolipopro-
eins and FMD showed no interaction with age, but
nivariate results are shown separately for subjects ages 3 to
and 12 to 18 years at baseline and also for the total cohort.
We also studied the utility of different childhood lipid
easures in predicting adulthood IMT 90th percentile
nd/or carotid plaque and, separately, brachial FMD10th
ercentile. Therefore, the receiver-operating characteristic
ROC) curves were generated for the childhood apoB/
poA-I ratio and the LDL/HDL-cholesterol ratio by plot-
ing sensitivity versus 1  specificity obtained from the
ultivariable logistic model also including all nonlipid risk
actors independently associating with ultrasound variables.
he c-value calculated from these models is conceptually
nalogous to the area under a ROC curve. The statistical
omparisons of the ROC curves of different predictive
d
lariables were carried out with a Statistical Analysis System
SAS, Cary, North Carolina) macro. This program per-
orms nonparametric statistical test for comparison of ROC
urves (26).
The statistical tests were performed with SAS version 9.1.
tatistical significance was inferred at a 2-tailed p value0.05.
alues for triglycerides, insulin, and CRP were log10-
ransformed before analyses due to skewed distributions. All
he analyses were repeated after excluding subjects taking
ipid-lowering (n 3) or antihypertensive medications (n
2), with essentially similar results.
esults
epresentativeness of the study population. The present
nalyses focused on the 879 subjects of the 21-year
ollow-up study with apolipoprotein data from 1980 (“study
ubjects”). The comparison of clinical characteristics of
tudy subjects and subjects excluded because of lacking
polipoprotein data is shown in Table 1. The distributions
f gender or age did not differ between the groups. The
aseline level (in 1980) of LDL cholesterol was slightly
ower among study subjects in comparison with those
xcluded from the present analyses. No statistically signifi-
linical Characteristics of Study Subjects and Thosexcluded Due to Missing Childhood Apolipoproteinata
Table 1
Clinical Characteristics of Study Subjects and
Those Excluded Due to Missing Childhood
Apolipoprotein Data
Study Subjects Excluded p Value
n 879 1,386
Male subjects (%) 45.7 44.4 0.56
Baseline characteristics in 1980
Age (yrs) 10.9 5.0 10.5 5.0 0.08
LDL cholesterol (mmol/l) 3.39 0.78 3.48 0.82 0.01
HDL cholesterol (mmol/l) 1.56 0.31 1.56 0.31 0.91
Triglycerides (mmol/l) 0.66 0.31 0.67 0.31 0.54
Systolic blood pressure (mm Hg) 112 12 113 12 0.19
BMI (kg/m2) 17.9 3.1 17.9 3.1 0.90
Insulin (mU/l) 9.8 6.0 9.7 5.9 0.39
CRP (mg/l) 0.9 2.7 1.1 3.2 0.80
Smoking (%)* 28.0 24.6 0.19
ApoA-I (g/l) 1.52 0.25
ApoB (g/l) 0.93 0.21
Characteristics in 2001
Age (yrs) 31.9 5.0 31.5 5.0 0.08
LDL cholesterol (mmol/l) 3.27 0.82 3.28 0.86 0.64
HDL cholesterol (mmol/l) 1.29 0.32 1.29 0.32 0.83
Triglycerides (mmol/l) 1.32 0.86 1.35 0.85 0.54
Systolic blood pressure (mm Hg) 117 13 116 13 0.19
BMI (kg/m2) 25.1 4.6 25.0 4.3 0.58
Smoking (%) 26.9 28.7 0.36
ApoA-I (g/l) 1.51 0.25 1.49 0.26 0.17
ApoB (g/l) 1.07 0.25 1.06 0.27 0.37
Carotid IMT (mm) 0.58 0.09 0.58 0.09 0.50
Brachial FMD (%) 8.12 4.43 7.92 4.42 0.30
Among subjects ages 12 to 18 years.
Apo apolipoprotein; BMI body mass index; CRP C-reactive protein; FMD flow-mediated
ilatation; HDL  high-density lipoprotein; IMT  intima-media thickness; LDL  low-density
ipoprotein.
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Apolipoproteins and Early Atherosclerosis July 22, 2008:293–9ant differences were seen in the levels of HDL cholesterol,
riglycerides, blood pressure, and BMI and smoking rates.
here were no differences between the 2 groups in apoli-
oprotein levels, IMT, and FMD measured in 2001.
ssociations between childhood and adolescent apoli-
oproteins and adulthood carotid IMT. In bivariate anal-
ses (performed for age- and gender-specific Z score
alues), apoB and the apoB/apoA-I ratio were directly
elated and apoA-I was inversely related to adulthood
MT in subjects ages 12 to 18 years at baseline. In
ubjects ages 3 to 9 years at baseline, these associations
ere nonsignificant (Table 2). In subjects ages 12 to 18
ears at baseline, the standardized regression coefficients
etween apolipoproteins and IMT were approximately 50%
igher compared with the regression coefficients between
onventional lipid measures and IMT (Table 2).
In multivariable analyses (performed for age- and gender-
pecific Z score values at the age of 12 to 18 years), the
irect associations between apoB and the apoB/apoA-I ratio
nd IMT and the inverse association between apoA-I and
MT were independent of other risk factors (Table 3). In
ddition, the associations between adolescent apolipopro-
eins and adulthood IMT remained significant after includ-
ng adulthood apolipoprotein values in the multivariable
odels (p  0.05).
When performing the multivariate analyses also with
ata from those subjects ages 3 to 9 years at baseline,
hildhood/adolescence (age 3 to 18 years) apoA-I (p 
.04), and the apoB/apoA-I ratio (p  0.02) were
ndependently associated, whereas apoB (p  0.09) was
ot associated with adulthood IMT.
The c-value for multivariable model predicting carotid
MT 90th percentile and/or carotid plaque incorporating
lso non-lipid risk factors independently associating with
MT (i.e., systolic blood pressure and smoking) was higher
or the adolescent apoB/apoA-I ratio compared with the
DL/HDL ratio (0.623 vs. 0.569, p  0.03) (Fig. 1). The
ifference remained similar when the LDL/HDL ratio was
eplaced with the non-HDL/HDL ratio (p  0.03).
Bivariate Relations Between Childhood/AdolescApolipoprot ins and Lipids on Adulth od Carotid
Table 2 Bivariate Relations Between ChildhApolipoproteins and Lipids on Adult
Age 3–9 Yrs (n 
 (95% CI)
ApoA-I 1 (8 to 8)
HDL cholesterol 10 (2 to 18)
ApoB 5 (13 to 3)
LDL cholesterol 4 (12 to 4)
Non-HDL cholesterol 5 (13 to 3)
ApoB/apoA1 ratio 4 (12 to 4)
LDL/HDL ratio 10 (18 to2)
Non-HDL/HDL ratio 10 (18 to2)
Beta values are regression coefficients (expressed in micrometers) for
are from regression analysis testing for linear relationship between risk facto
CI  confidence interval; other abbreviations as in Table 1.ssociations between childhood and adolescent apoli-
oproteins and adulthood brachial FMD. In subjects
ges 3 to 18 years at baseline, apoB and the apoB/apoA-I
atio were indirectly related and childhood apoA-I was
irectly related to adulthood FMD (Table 4). Conventional
ipids measured in childhood and adolescence were not
ssociated with adulthood FMD (Table 4). The associations
etween apolipoproteins (analyses performed for age- and
ender-specific Z score values) and FMD were independent
f other childhood and adolescent risk factors and brachial
rtery diameter (Table 5). These associations remained
ignificant after including adulthood apolipoprotein values
n multivariable models (p  0.05).
The apoB/apoAI ratio had a higher c-value compared
ith the LDL/HDL ratio (0.613 vs. 0.602) in predicting
dult brachial FMD 10th percentile, but this difference
as not significant (p  0.46).
iscussion
isk factors operating in early life might have long-term
ffects on arterial health. At present, however, there are
Measured 21 Years Later
Adolescence
Carotid IMT Measured 21 Years Later
Carotid IMT
Age 12–18 Yrs (n  472)
Value  (95% CI) p Value
.95 12 (22 to2) 0.01
.009 7 (17 to 3) 0.11
.16 18 (8 to 28) 0.001
.25 11 (1 to 21) 0.02
.19 12 (2 to 22) 0.009
.26 24 (14 to 34) 0.001
.01 16 (6 to 26) 0.004
.02 16 (6 to 26) 0.003
change (specific for age and gender) in continuous variables. p values
ultivariable Relations Between Adolescent ApoBnd ApoA-I and Adulthood Carotid IMT Adjustedith Other Risk Fac ors in Subjects Ages 12 to 18ears t Baseline
Table 3
Multivariable Relations Between Adolescent ApoB
and ApoA-I and Adulthood Carotid IMT Adjusted
With Other Risk Factors in Subjects Ages 12 to 18
Years at Baseline
 (95% CI) p Value
ApoA-I* 11 (19 to3) 0.01
ApoB* 17 (8 to 26) 0.001
Triglycerides 1 (9 to 11) 0.76
Systolic blood pressure 16 (8 to 24) 0.001
BMI 3 (7 to 13) 0.61
Insulin 2 (12 to 8) 0.61
CRP 2 (12 to 8) 0.65
Smoking 32 (12 to 52) 0.002
 472. Values are regression coefficients (expressed in micrometers) for a 1-SD change (specific
or age and gender) in continuous variables and for the presence/absence of smoking. *When
poB and apoA-I were replaced with their ratio, the ratio was significantly associated with increased
MT (  23 [15 to 31], p  0.001).
Abbreviations as in Tables 1 and 2.enceIMT
ood/
hood
407)
p
0
0
0
0
0
0
0
0
a 1-SD
rs and IMT.
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July 22, 2008:293–9 Apolipoproteins and Early Atherosclerosisimited data linking childhood risk factors to cardiovascular
isease end points to support this idea. It has been shown—
egarding lipid risk factors—that exposure to high levels of
DL cholesterol in childhood and adolescence predicts the
evelopment of increased carotid IMT in adulthood
10,16,17). In the present study, we found that apoB and
poA-I levels and their ratio assessed at an early age were
redictive of adulthood carotid IMT and brachial FMD.
hese relations were independent of apolipoprotein levels in
dulthood. In addition, we found that a high apoB/apoA-I
atio was superior to conventional lipid measures in predict-
ng abnormal IMT.
Apolipoproteins have been consistently shown to predict
ardiovascular morbidity and mortality (2–8,27). In the
Figure 1 ROC Curves for Adolescent Lipid Measures Predicting
Adulthood IMT >90th Percentile or Carotid Plaque
Ages 12 to 18 years, n  472. The diagonal line indicates a test with an area
under the receiver operating characteristics curve of 0.5. In addition to lipid mea-
sures, the models included those risk factors significantly associated with intima-
media thickness in multivariate model (blood pressure, smoking). The values for
continuous variables were age- and gender-specific Z scores. ApoA-I  apolipopro-
tein A-I; ApoB  apolipoprotein B; HDL  high-density lipoprotein (cholesterol);
IMT  intima-media thickness; LDL  low-density lipoprotein (cholesterol); ROC 
receiver-operating characteristic.
ivariate Relations Between Childhood/Adolescent Apolipoproteinsnd Lipids on Adulthood Brachial FMD M asured 21 Years Later
Table 4 Bivariate Relations Between Childhood/Adolescent Apoland Lipids on Adulthood Brachial FMD Measured 21
Age 3–9 Yrs (n  375)
 (95% CI) p Value
ApoA-I 0.48 (0.02 to 0.94) 0.04 0
HDL cholesterol 0.03 (0.43 to 0.49) 0.91 0
ApoB 0.36 (0.82 to 0.10) 0.12 0
LDL cholesterol 0.09 (0.55 to 0.37) 0.70 0
Non-HDL cholesterol 0.05 (0.51 to 0.41) 0.84 0
ApoB/apoA1 ratio 0.56 (1.02 to0.10) 0.01 0
LDL/HDL ratio 0.09 (0.55 to 0.37) 0.70 0
Non-HDL/HDL ratio 0.04 (0.50 to 0.42) 0.85 0
eta values are regression coefficients (expressed in percents) for a 1-SD change (specific for age
etween risk factors and FMD.
Abbreviations as in Tables 1 and 2.NTERHEART (Effect of Potentially Modifiable Risk
actors Associated with Myocardial Infarction in 52 Coun-
ries) study (27), a high apoB/apoA-I ratio was the strongest
isk factor for acute myocardial infarction. The population-
ttributable risk associated with the apoB/apoA1 ratio was
pproximately 50%, suggesting that the apoB/apoA-I ratio
lone accounts for about one-half of the risk of an acute
yocardial infarction. In addition, apolipoproteins might be
uperior to LDL cholesterol and HDL cholesterol in
redicting coronary heart disease (CHD) and stroke (2–8).
n the EPIC-Norfolk (European Prospective Investigation
f Cancer, Norfolk) Study (8), the apoB/apoA-I ratio was
ssociated with future CHD events, independent of con-
entional lipid measurements. In the AMORIS study (4),
he apoB/apoA-I ratio was a stronger marker of CHD risk
ompared with the total/HDL-cholesterol ratio, LDL/
DL-cholesterol ratio, or non–HDL/HDL-cholesterol ra-
io. In a recent report from the Framingham Offspring
tudy (28), apolipoproteins were somewhat better than
onventional lipid measures in predicting CHD risk, but the
oteins
rs Later
Brachial FMD
e 12–18 Yrs (n  438) All (n  813)
95% CI) p Value  (95% CI) p Value
01 to 0.85) 0.04 0.45 (0.13 to 0.77) 0.004
0.25 to 0.59) 0.43 0.10 (0.22 to 0.42) 0.51
0.76 to 0.08) 0.11 0.35 (0.67 to0.03) 0.03
0.57 to 0.27) 0.49 0.13 (0.45 to 0.19) 0.44
0.53 to 0.31) 0.62 0.08 (0.40 to 0.24) 0.61
0.99 to0.11) 0.01 0.56 (0.88 to0.24) 0.001
0.58 to 0.26) 0.45 0.13 (0.45 to 0.19) 0.41
0.56 to 0.32) 0.58 0.09 (0.41 to 0.23) 0.59
nder) in continuous variables. p values are from regression analysis testing for linear relationship
ultivariable Relations Between Childhood anddolescenc ApoB a d ApoA-I and A ulthoodrachi l FMD Adjuste Wi h Other Risk Factors andDiameter in Subj cts Ages 3–18 Yea taseline
Table 5
Multivariable Relations Between Childhood and
Adolescence ApoB and ApoA-I and Adulthood
Brachial FMD Adjusted With Other Risk Factors and
Brachial Diameter in Subjects Ages 3–18 Years at
Baseline
 (95% CI) p Value
ApoA-I* 0.47 (0.17 to 0.77) 0.003
ApoB* 0.38 (0.68 to0.08) 0.02
Baseline brachial diameter 1.25 (1.55 to0.95) 0.001
Triglycerides 0.31 (0.01 to 0.63) 0.054
Systolic blood pressure 0.06 (0.26 to 0.38) 0.69
BMI 0.74 (0.42 to 1.06) 0.001
Insulin 0.06 (0.38 to 0.26) 0.71
CRP 0.07 (0.23 to 0.37) 0.66
Smoking 0.06 (0.90 to 0.78) 0.89
 805. Values are regression coefficients (expressed in percents) for a 1-SD change (specific for
ge and gender) in continuous variables and for the presence/absence of smoking.
When apoB and apoA-I were replaced with their ratio, the ratio was significantly associated with
ecreased FMD (  0.60 [0.90 to 0.30], p  0.001).
Abbreviations as in Tables 1 and 2.ipopr
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Apolipoproteins and Early Atherosclerosis July 22, 2008:293–9ifference was statistically nonsignificant. In that study
poA-I was associated with CHD risk only in men, whereas
poB predicted CHD in both men and women (28). In the
DAY (Pathobiological Determinants of Atherosclerosis in
outh) study (29), apolipoproteins have been associated
ith postmortem arterial lesions. In a recent cross-sectional
nalysis from the Bogalusa Heart Study (30) in 1,062 black
nd white subjects ages 24 to 43 years, apoB was directly
elated and apoA-I was indirectly related to carotid IMT.
owever, to our knowledge, there are no prior longitudinal
ata linking childhood apolipoproteins with later vascular
ndings. The present results are in line with earlier reports
uggesting that both the concentrations of apoB and apoA-I
eflect lipoprotein profile predisposing to atherosclerosis.
We found that youth apoB and apoA-I were both
onsistently superior to conventional LDL cholesterol and
DL cholesterol measurements in predicting abnormal
arotid IMT in adulthood. This might suggest that the
oncentrations of apolipoproteins are better indicators of the
unction of serum lipoprotein particles than their cholesterol
ontent. Apolipoproteins B and A-I serve as structural
roteins for the very-low-density to low-density lipoprotein
pectrum (LDL, VLDL, IDL, and lipoprotein [a]) and
DL and act as determinants of the metabolic fate of these
ipoproteins (31). In general, apoB-containing lipoproteins
arry lipids from liver and gut to the sites of use, whereas
poA-I–containing particles mediate the reverse cholesterol
ransport and bring excess cholesterol from peripheral tis-
ues to the liver (31). As discussed by Walldius and Jungner
32), there are advantages in measuring apoB and apoA-I.
heir concentrations reflect the particle numbers of their
espective lipoprotein classes and thus the opposite aspects
f the risk. A high apoB/apoA-I ratio indicates the number
f atherogenic lipoprotein particles, which are likely to be
eposited in the arterial wall. In line, we have previously
hown an age-related increase in the content of apoB and a
ecrease in the apoA-I/apoB ratio in the lesion-free aortic
ntimas of children and adolescents, changes that could
avor the deposition of lipids in the arteries (33).
In cross-sectional settings, HDL cholesterol concentration
easured in children (18,19) and young adults (16,17,20) has
een shown to associate inversely with carotid IMT. However,
n the prior reports from longitudinal studies, childhood HDL
holesterol concentrations have not been predictive of adult
arotid IMT (10,17). We observed that concentrations of
DL particles’ major apoA-I were predictive of both adult-
ood carotid IMT and brachial FMD. Thus, this is the first
emonstration that childhood HDL metabolism might influ-
nce the risk of developing subclinical atherosclerosis in adult-
ood. The HDL particles have several potential antiathero-
enic properties. They promote the efflux of cholesterol from
acrophages and form cells in the artery wall and have
nti-inflammatory, antithrombotic, profibrinolytic, and antiox-
dant properties (34). The HDL particles also inhibit adhesion
olecule expression and stimulate endothelial nitric oxide
roduction (34). These functions seem to involve apoA-I,hich might therefore be central to the role of HDL choles-
erol in protecting against vascular disease (35).
In the present study, apolipoprotein measurements be-
ame predictive for adulthood carotid IMT only at adoles-
ence. Similarly, we have previously reported that conven-
ional risk factors (i.e., LDL cholesterol, blood pressure, and
besity) are associated with adulthood IMT when assessed
n adolescence but not in childhood (10). These findings
mplicate adolescence as a critical period of time when
xposure to risk factors might have measurable long-term
ffects on atherosclerosis.
tudy limitations. Our study has limitations. We had
hildhood data on apolipoproteins only from a subcohort of
he 2,265 subjects participating in the 21-year follow-up
tudy in 2001. Nevertheless, the study cohort still remained
ubstantially large with 879 subjects, and its clinical char-
cteristics were virtually similar to those of the rest of the
ohort. Apolipoprotein measurements were performed with
adial immunodiffusion method in 1980 and turbidometric
ethod in 2001. However, we have previously shown that
hese methods are comparable (36). Because our study
ohort comprises young adults without clinical athero-
clerotic diseases, we are not able to study associations
etween risk factors and cardiovascular events. Instead,
e have used vascular ultrasound measures as indicators
f an atherogenic process. Although the apoB/apoA-I
atio was a better marker than the LDL/HDL ratio in
redicting abnormal carotid IMT in adulthood, the
-value for the apoB/apoA-I ratio was only 9% greater
han for the LDL/HDL ratio. The absolute c-values were
omparatively low and clearly lower than achieved with
isk factors in adult life in predicting clinical end points
4,8). Nevertheless, our data suggest that apolipoproteins
ight have additional value over conventional lipid
easurements in pediatric cardiovascular risk assessment.
ther advantages include methodological issues and the
ossibility to use non-fasting blood samples (32).
onclusions
he present data suggest that the concentrations of LDL
nd HDL particles’ major apolipoproteins B and A-I
easured in early life are related to subclinical atheroscle-
osis in adulthood. These findings support the role of serum
ipoproteins in the pathophysiology of atherosclerosis. Apo-
ipoproteins B and A-I measured in children and adoles-
ents might have value in pediatric lipid risk assessment.
eprint requests and correspondence: Dr. Markus Juonala, P.O.
ox 52, 20521 Turku, Finland. E-mail: markus.juonala@utu.fi.
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